Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
α-D-mannose-containing glycoproteins on granulocyte precursor cells represent a specific class of glycosylated surface proteins characterized by the presence of alpha-D-mannose residues. These glycoproteins serve as critical docking sites for various ligands, including endogenous lectins and microbial adhesins such as the Type 1 fimbriae of Escherichia coli. In the context of granulocyte precursors and mature neutrophils, these residues facilitate essential biological processes like cell adhesion, migration, and the recognition of pathogens during the innate immune response. From a therapeutic perspective, these glycoproteins are targeted primarily to modulate immune activity or prevent bacterial colonization. For instance, exogenous D-mannose is utilized as a competitive inhibitor to prevent bacteria from binding to these host glycoproteins, thereby reducing the incidence of infections like urinary tract infections. Additionally, plant-derived lectins such as Concanavalin A are frequently used in research settings to bind these targets and stimulate granulocyte activity. Understanding the distribution and density of these mannosylated structures is vital for developing anti-adhesive therapies and targeted drug delivery systems.
Competitive inhibition of bacterial adhesion (e.g., by D-Mannose) or lectin-mediated cell stimulation (e.g., by Concanavalin A).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on α-D-mannose-containing glycoproteins on granulocyte precursor cells.